Sahjpaul R, Girotti M
Department of Clinical Neurological Sciences, London Health Sciences Center, Ontario, Canada.
Can J Neurol Sci. 2000 May;27(2):143-7.
The purpose of this study was to obtain information from Canadian neurosurgeons regarding their opinions on, and utilization of, intracranial pressure (ICP) monitoring for severe traumatic brain injury (TBI).
A brief survey was sent to practicing Canadian neurosurgeons questioning them about their utilization of, and confidence in, intracranial pressure monitoring in the management of patients with severe TBI.
One hundred and ninety-six surveys were mailed. There were 103 responses for a response rate of 52.6%. The vast majority of responding neurosurgeons (98.1%) utilized ICP monitoring in the management of patients with severe TBI, with most (63.4%) using it in more than 75% of their patients, 14.9% using it in 50-75% of patients, 14.9% in 25-50% of patients, and 6.9% using it in less than 25% of patients. The level of confidence that routine monitoring improves outcome from severe TBI ranged from 23.3% having a low level of confidence, 56.3% having an intermediate level of confidence, to 20.4% having a high level of confidence. Most respondents (78.6%) felt that some form of prospective trial evaluating the role of ICP monitoring in improving outcome from severe TBI was warranted; 17.4% felt such a trial was not warranted and 3.9% were uncertain.
While ICP monitoring has gained almost universal acceptance among responding Canadian neurosurgeons, their level of confidence that routine monitoring improves outcome from severe TBI was quite variable, with only 20.4% of respondents having a high level of confidence. Over 75% of respondents felt that some form of prospective trial evaluating the utility of ICP monitoring is warranted. This information is being used in consideration of a prospective trial addressing this issue.
本研究旨在从加拿大神经外科医生处获取有关其对重度创伤性脑损伤(TBI)颅内压(ICP)监测的看法及应用情况的信息。
向执业的加拿大神经外科医生发送了一份简短调查问卷,询问他们在重度TBI患者管理中对ICP监测的应用情况及信心。
共邮寄了196份调查问卷。收到103份回复,回复率为52.6%。绝大多数回复的神经外科医生(98.1%)在重度TBI患者管理中使用ICP监测,其中大多数(63.4%)在超过75%的患者中使用,14.9%在50 - 75%的患者中使用,14.9%在25 - 50%的患者中使用,6.9%在不到25%的患者中使用。认为常规监测能改善重度TBI预后的信心水平差异较大,23.3%信心水平低,56.3%信心水平中等,20.4%信心水平高。大多数受访者(78.6%)认为有必要进行某种形式的前瞻性试验来评估ICP监测在改善重度TBI预后中的作用;17.4%认为无需进行此类试验,3.9%不确定。
虽然ICP监测在回复的加拿大神经外科医生中几乎已得到普遍认可,但他们对常规监测能改善重度TBI预后的信心水平差异很大,只有20.4%的受访者信心水平高。超过75%的受访者认为有必要进行某种形式的前瞻性试验来评估ICP监测的效用。该信息正被用于考虑针对此问题开展一项前瞻性试验。